Report Feature
The material technologies in orthopedic device have undergone significant change in recent years, with polyaryletherketones (PAEKs) based orthopedic implant material to metals and biologic orthopedic implants. The rising wave of new technologies such as polymers, metals and biologics are creating significant potential for advanced orthopedic devices in various medical platforms due to its improved strength and durability.
In orthopedic device market, various material technologies such as polymers, metals, ceramics, and biologics are used in the hip replacement, knee replacement, ankle replacement, and shoulder replacement applications. Increasing incidence of road accidents & sports injuries and spurring demand for minimally invasive surgical procedures are creating new opportunities for various orthopedic device technologies.
Some of the latest technological developments by various countries in the orthopedic device market are as follows:
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global orthopedic device technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology Type [$M shipment analysis from 2018 to 2030]:
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the orthopedic device companies profiled in this report include Medtronic, DePuy Synthes, Stryker Corporation, NuVasive, Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, K2M Group Holdings, and RTI Surgical.
Below are the latest technological developments from top companies in the orthopedic device market:
Q.1 What are some of the most promising and high-growth technology opportunities for the orthopedic device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in orthopedic device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in orthopedic device market?
Q.6 What are the latest developments in orthopedic device technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this orthopedic device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this orthopedic device technology space?
In orthopedic device market, various material technologies such as polymers, metals, ceramics, and biologics are used in the hip replacement, knee replacement, ankle replacement, and shoulder replacement applications. Increasing incidence of road accidents & sports injuries and spurring demand for minimally invasive surgical procedures are creating new opportunities for various orthopedic device technologies.
Some of the latest technological developments by various countries in the orthopedic device market are as follows:
- United States: Johnson & Johnson received FDA approval for a new generation of knee replacement implants designed to last longer and improve patient outcomes. This signifies a significant advancement in Polymers Based technology within the US orthopedic device market.
- France: Stryker Corporation, a major player in the orthopedic device industry, secured CE Mark approval for its additively manufactured personalized tibial tray for complex knee surgeries. This development highlights the progress of Metals Based technology, particularly in the area of 3D printing for custom-made implants.
- Germany: Zimmer Biomet, a German orthopedic device company, partnered with a leading research institute to develop next-generation biocompatible ceramics for hip and spine applications. This initiative indicates advancements in Ceramics Based technology and reflects the focus on improved biocompatibility for better patient outcomes.
- China: Exactech, a medical device company, obtained government approval for clinical trials of its bone morphogenetic protein (BMP) product for spinal fusion procedures. This marks a step forward in Biologics Based technology, specifically in the area of bone growth stimulating agents for spinal surgeries.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global orthopedic device technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology Type [$M shipment analysis from 2018 to 2030]:
- Polymers Based
- Metals Based
- Ceramics Based
- Biologics Based
-
Hip Replacement
- Polymers Based
- Metals Based
- Ceramics Based
- Biologics Based
-
Knee Replacement
- Polymers Based
- Metals Based
- Ceramics Based
- Biologics Based
-
Ankle Replacement
- Polymers Based
- Metals Based
- Ceramics Based
- Biologics Based
-
Shoulder Replacement
- Polymers Based
- Metals Based
- Ceramics Based
- Biologics Based
-
Others
- Polymers Based
- Metals Based
- Ceramics Based
- Biologics Based
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the orthopedic device companies profiled in this report include Medtronic, DePuy Synthes, Stryker Corporation, NuVasive, Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, K2M Group Holdings, and RTI Surgical.
Below are the latest technological developments from top companies in the orthopedic device market:
- Stryker Corporation announced the launch of its new Triathlon® Total Ankle System, a polymer-based implant designed to improve patient outcomes in total ankle replacements. This launch caters to the growing demand for minimally invasive procedures and faster recovery times.
- Zimmer Biomet received FDA approval for its G7® Tibial Tray with Polytetrafluoroethylene (PTFE) Coating, a polymer-based innovation that aims to reduce implant loosening and improve long-term stability in total knee replacements.
- Johnson & Johnson (Depuy Synthes) announced collaboration with the American Academy of Orthopaedic Surgeons (AAOS) to develop educational programs on the benefits and proper use of metal-based implants in fracture repair surgeries. This initiative highlights the company's focus on improving patient education and surgical outcomes.
- Exactech announced a CAPEX (capital expenditure) increase of 15% earmarked for expanding their manufacturing capacity for metal-based knee and hip replacement implants. This investment reflects the anticipated growth in demand for these products.
- B. Braun Melsungen announced a strategic partnership with a leading ceramics manufacturer to develop a new generation of ceramic-on-ceramic bearings for hip replacements. This collaboration aims to improve wear resistance and longevity of these implants.
- The European Union is proposing new regulations for stricter quality control and biocompatibility testing of ceramic-based orthopedic devices. This initiative highlights the growing focus on patient safety and long-term device performance.
- Medtronic launched its next-generation INBONE® Bone Morphogenetic Protein (BMP) implant for spinal fusion surgeries. This biologics-based product boasts faster bone formation and improved fusion rates compared to previous iterations.
Q.1 What are some of the most promising and high-growth technology opportunities for the orthopedic device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in orthopedic device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in orthopedic device market?
Q.6 What are the latest developments in orthopedic device technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this orthopedic device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this orthopedic device technology space?
Table of Contents
1. Executive Summary 2. Technology Landscape 2.1. Technology Background and Evolution 2.2. Technology and Application Mapping 2.3. Supply Chain
3. Technology Readiness 3.1. Technology Commercialization and Readiness 3.2. Drivers and Challenges in Orthopedic Device Technologies 3.3. Competitive Intensity 3.4. Regulatory Compliance
4. Technology Trends and Forecasts Analysis from 2018-2030 4.1. Orthopedic Device Opportunity 4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
5. Technology Opportunities (2018-2030) by Region 5.1. Orthopedic Device Market by Region 5.2. North American Orthopedic Device Technology Market
6. Latest Developments and Innovations in the Orthopedic Device Technologies 7. Companies / Ecosystem 7.1. Product Portfolio Analysis 7.2. Market Share Analysis 7.3. Geographical Reach
8. Strategic Implications 8.1. Implications 8.2. Growth Opportunity Analysis
9. Company Profiles of Leading Players 9.1. Medtronic 9.2. DePuy Synthes 9.3. Stryker Corporation 9.4. NuVasive 9.5. Zimmer Biomet Holdings 9.6. Globus Medical 9.7. Alphatec Holdings 9.8. Orthofix International 9.9. K2M Group Holdings 9.10. RTI Surgical
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
